MIR1224: A Drug Target / Disease Biomarker (G100187716)
MIR1224: A Drug Target / Disease Biomarker
MIR1224 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.
One of the unique features of MIR1224 is its ability to interact with other proteins that are expressed in the brain, such as the protein alpha-synuclein. This interaction between MIR1224 and alpha-synuclein is of particular interest, as it suggests that MIR1224 may play a role in the structure and function of the brain.
MIR1224 is also known for its ability to interact with the protein Tau. Tau is a protein that is involved in the formation of neurofibrillary tangles, which are thought to contribute to the development of Alzheimer's disease.
In addition to its potential role in the brain, MIR1224 has also been shown to play a role in the regulation of inflammation. This is important because inflammation is thought to contribute to a number of diseases, including heart disease and diabetes.
MIR1224 has also been shown to interact with the protein NF-kappa-B. NF-kappa-B is a protein that is involved in the regulation of inflammation and cell growth. This suggests that MIR1224 may play a role in the regulation of inflammation and cell growth.
In conclusion, MIR1224 is a protein that has been shown to interact with a number of proteins that are involved in the structure and function of the body. These interactions suggest that MIR1224 may be a drug target or biomarker for a number of diseases. Further research is needed to fully understand the role of MIR1224 in the regulation of the body's tissues.
Protein Name: MicroRNA 1224
The "MIR1224 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1224 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2
